RXRX Sale Disclosure
Khan Najat · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$78.82K
Khan Najat CEO And President
RXRX
Transaction date
Sep 8, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 2 days later
RXRX daily price context
Close on/before transaction
$3.44
Sep 8, 2026
Close before public filing
$3.21
Sep 9, 2026
Return since public filing
-0.47%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 22,408 shares @ $3.52
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001601830-26-000105
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$78.82K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Sale | Sep 8, 2026 | $78.82K |